FI960487L - Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia - Google Patents
Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia Download PDFInfo
- Publication number
- FI960487L FI960487L FI960487A FI960487A FI960487L FI 960487 L FI960487 L FI 960487L FI 960487 A FI960487 A FI 960487A FI 960487 A FI960487 A FI 960487A FI 960487 L FI960487 L FI 960487L
- Authority
- FI
- Finland
- Prior art keywords
- benzopyrans
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939316111A GB9316111D0 (en) | 1993-08-04 | 1993-08-04 | Benzopyrans |
| PCT/EP1994/002387 WO1995004730A1 (en) | 1993-08-04 | 1994-07-18 | Benzopyrans and pharmaceutical compositions containing them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI960487A7 FI960487A7 (fi) | 1996-02-02 |
| FI960487A0 FI960487A0 (fi) | 1996-02-02 |
| FI960487L true FI960487L (fi) | 1996-02-02 |
Family
ID=10739921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI960487A FI960487L (fi) | 1993-08-04 | 1994-07-18 | Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US5912244A (cs) |
| EP (1) | EP0712398B1 (cs) |
| JP (1) | JP2871098B2 (cs) |
| KR (1) | KR0175532B1 (cs) |
| CN (1) | CN1128536A (cs) |
| AT (1) | ATE152716T1 (cs) |
| AU (1) | AU684817B2 (cs) |
| CA (1) | CA2168563C (cs) |
| CO (1) | CO4230234A1 (cs) |
| CZ (1) | CZ281853B6 (cs) |
| DE (1) | DE69403084T2 (cs) |
| DK (1) | DK0712398T3 (cs) |
| EC (1) | ECSP941140A (cs) |
| EG (1) | EG20525A (cs) |
| ES (1) | ES2102870T3 (cs) |
| FI (1) | FI960487L (cs) |
| GB (1) | GB9316111D0 (cs) |
| GR (1) | GR3023521T3 (cs) |
| HU (1) | HUT75120A (cs) |
| IL (1) | IL110488A (cs) |
| NO (1) | NO960441D0 (cs) |
| NZ (1) | NZ271344A (cs) |
| PE (1) | PE56894A1 (cs) |
| PL (1) | PL312788A1 (cs) |
| SG (1) | SG42817A1 (cs) |
| TW (1) | TW333532B (cs) |
| WO (1) | WO1995004730A1 (cs) |
| ZA (1) | ZA945774B (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5573758A (en) * | 1995-04-28 | 1996-11-12 | Allergan | Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
| US5869478A (en) * | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
| IL127379A0 (en) * | 1996-06-07 | 1999-10-28 | Procter & Gamble | Dihydrobenzopyran and related compounds useful as anti-inflammatory agents |
| US6333352B1 (en) * | 2000-04-05 | 2001-12-25 | Mimicking Man Manually, Inc. | Method of treating benign positional vertigo |
| CA2444031C (en) * | 2001-04-16 | 2012-02-21 | Schering Corporation | 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| JP2005505586A (ja) * | 2001-10-04 | 2005-02-24 | ワイス | ５−ヒドロキシトリプタミン−６リガンドとしてのクロマン誘導体 |
| NZ539903A (en) * | 2002-11-12 | 2008-02-29 | Warner Lambert Co | Method of stimulating hair growth using benzopyrans |
| CA2555741C (en) * | 2004-02-12 | 2010-03-23 | Warner-Lambert Company Llc | Method of stimulating hair growth |
| US20090110892A1 (en) * | 2004-06-30 | 2009-04-30 | General Electric Company | System and method for making a graded barrier coating |
| JP2008506682A (ja) * | 2004-07-16 | 2008-03-06 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 発毛促進剤 |
| MXPA06014390A (es) * | 2004-07-19 | 2007-10-02 | Warner Lambert Co | Formulacion para estimular el crecimiento del pelo. |
| KR100965190B1 (ko) * | 2004-12-21 | 2010-06-24 | 에프. 호프만-라 로슈 아게 | 크로만 유도체 및 중추 신경계 장애의 치료에서 그의 용도 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3835011A1 (de) * | 1988-10-14 | 1990-04-19 | Merck Patent Gmbh | Chromanderivate |
| DE3881714D1 (de) * | 1987-02-04 | 1993-07-22 | Hoechst Ag | Alkylsubstituierte n-benzopyranyllactame, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen. |
| DE3703227A1 (de) * | 1987-02-04 | 1988-08-18 | Hoechst Ag | Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen |
| DE3811017A1 (de) * | 1988-03-31 | 1989-10-19 | Hoechst Ag | Ungesaettigte n-benzopyranyllactame |
| AU628331B2 (en) * | 1988-05-06 | 1992-09-17 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Chroman derivatives |
| EP0346724A1 (de) * | 1988-06-16 | 1989-12-20 | MERCK PATENT GmbH | Chromanderivate |
| DE3824446A1 (de) * | 1988-07-19 | 1990-01-25 | Hoechst Ag, 6230 Frankfurt | Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege |
| DE3827532A1 (de) * | 1988-08-13 | 1990-03-01 | Hoechst Ag | 6-aroyl-substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen |
| DE3918041A1 (de) * | 1989-06-02 | 1990-12-06 | Merck Patent Gmbh | Chromanderivate |
| US5061813A (en) * | 1990-04-02 | 1991-10-29 | E. R. Squibb & Sons, Inc. | Substituted cyanoimino benzopyranes |
| GB2242628A (en) * | 1990-04-06 | 1991-10-09 | Sandoz Ltd | Asthma prophylactic use of K+ channel activators |
| TW244350B (cs) * | 1991-12-14 | 1995-04-01 | Hoechst Ag | |
| JPH0673061A (ja) * | 1992-01-18 | 1994-03-15 | Hoechst Ag | ６−置換クロメン類のエナンチオ選択的エポキシ化方法 |
-
1993
- 1993-08-04 GB GB939316111A patent/GB9316111D0/en active Pending
-
1994
- 1994-07-08 TW TW083106236A patent/TW333532B/zh active
- 1994-07-18 AU AU74948/94A patent/AU684817B2/en not_active Ceased
- 1994-07-18 KR KR1019960700566A patent/KR0175532B1/ko not_active Expired - Fee Related
- 1994-07-18 NZ NZ271344A patent/NZ271344A/en unknown
- 1994-07-18 HU HU9600238A patent/HUT75120A/hu unknown
- 1994-07-18 US US08/591,500 patent/US5912244A/en not_active Expired - Fee Related
- 1994-07-18 CA CA002168563A patent/CA2168563C/en not_active Expired - Fee Related
- 1994-07-18 EP EP94924788A patent/EP0712398B1/en not_active Expired - Lifetime
- 1994-07-18 ES ES94924788T patent/ES2102870T3/es not_active Expired - Lifetime
- 1994-07-18 CZ CZ96331A patent/CZ281853B6/cs not_active IP Right Cessation
- 1994-07-18 WO PCT/EP1994/002387 patent/WO1995004730A1/en active IP Right Grant
- 1994-07-18 DK DK94924788.6T patent/DK0712398T3/da active
- 1994-07-18 PL PL94312788A patent/PL312788A1/xx unknown
- 1994-07-18 AT AT94924788T patent/ATE152716T1/de not_active IP Right Cessation
- 1994-07-18 SG SG1995002213A patent/SG42817A1/en unknown
- 1994-07-18 JP JP7506179A patent/JP2871098B2/ja not_active Expired - Fee Related
- 1994-07-18 CN CN94192981A patent/CN1128536A/zh active Pending
- 1994-07-18 FI FI960487A patent/FI960487L/fi unknown
- 1994-07-18 DE DE69403084T patent/DE69403084T2/de not_active Expired - Fee Related
- 1994-07-25 PE PE1994247480A patent/PE56894A1/es not_active Application Discontinuation
- 1994-07-28 IL IL11048894A patent/IL110488A/xx not_active IP Right Cessation
- 1994-08-03 ZA ZA945774A patent/ZA945774B/xx unknown
- 1994-08-03 EG EG46794A patent/EG20525A/xx active
- 1994-08-04 CO CO94034292A patent/CO4230234A1/es unknown
- 1994-08-04 EC EC1994001140A patent/ECSP941140A/es unknown
-
1996
- 1996-02-02 NO NO960441A patent/NO960441D0/no not_active Application Discontinuation
-
1997
- 1997-05-23 GR GR970401169T patent/GR3023521T3/el unknown
-
1999
- 1999-04-09 US US09/288,975 patent/US6071938A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI944832A7 (fi) | Farmaseuttinen koostumus | |
| BR1100824A (pt) | Composto e composição farmacêutica | |
| PT589843E (pt) | Composicoes farmaceuticas contendo ciclosporinas | |
| FI945731A7 (fi) | Tiatsolidiinijohdannaiset ja farmaseuttiset koostumukset, jotka sisältävät niitä | |
| BR1100329A (pt) | Composto e formulação farmacêutica | |
| FI941747L (fi) | Koostumuksia ja niiden käyttöjä | |
| FI945524L (fi) | Aerosolilääkekoostumuksia | |
| EE03108B1 (et) | Farmatseutiline kompositsioon | |
| FI922316L (fi) | Farmaceutisk sammansaettning | |
| FI922252L (fi) | Farmaceutisk sammansaettning | |
| FI934274A7 (fi) | N-sulfonyyli-2-oksi-indolijohdannaiset, niiden valmistus ja niitä sisä ltävät farmaseuttiset koostumukset | |
| BR9200058A (pt) | Composto e composicao farmaceutica | |
| FI941836A7 (fi) | 3-deoksioligosakkaridit, menetelmiä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| ITMI932540A0 (it) | Composizione farmaceutica | |
| MX9200622A (es) | Composicion farmaceutica | |
| FI960487A7 (fi) | Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia | |
| FI943705L (fi) | Farmaseuttiset koostumukset | |
| FI971427A7 (fi) | Peptidit ja niitä sisältävät farmaseuttiset koostumukset | |
| FI940726A7 (fi) | Farmaseuttiset koostumukset | |
| LV10579A (lv) | Farmaceitiska kompozicija | |
| FI934387A0 (fi) | 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner | |
| ITMI930181A1 (it) | Composizione farmaceutica contenente n-acetil-cisteina | |
| BR1100809A (pt) | Composto e composição farmacêutica | |
| BR1100293A (pt) | Composto e composição farmacêutica | |
| BR1100200A (pt) | Composição farmacêutica |